News | Proton Therapy | May 25, 2022

Proof of feasibility of downsizing to the world's smallest size, and moved to final confirmation for application for PMDA approval

The ultra-compact proton therapy system used in the POC (Photo: Business Wire)

The ultra-compact proton therapy system used in the POC (Photo: Business Wire)


May 25, 2022 — B dot Medical Inc. and Research Center for Nuclear Physics, Osaka University (RCNP) have conducted a Proof of Concept (POC) of the ultra-compact proton therapy system under development and confirmed that the proton beam generated by an accelerator was bent inside the superconducting bending magnet in the system and irradiated to the isocenter (*1). That proves the feasibility of the development concept of downsizing the device and is a major step forward in improving access to cancer treatment with fewer side effects.

This POC was conducted as part of the International Joint Usage/Research Center program promoted by the Research Center for Nuclear Physics (RCNP) at Osaka University and is also the first experimental research using the upgraded AVF cyclotron beam at the Accelerator Facility of the RCNP. In the POC, the proton beam generated by the accelerator was passed through a superconducting bending magnet (*2) developed in-house, and it was confirmed that the proton beam was irradiated to the isocenter by being bent to an arbitrary angle in the bending magnet.

For more information: https://bdotmed.co.jp/en/

References:

*1

The Isocenter is the intersection of each mechanical rotation axis.

 

In radiation therapy, it refers to the area where the radiation is most concentrated.

 

(by “Guidelines of Physical and Technological Quality Assurance for Particle Beam Therapy”)

 

 

*2

Press release, June 25, 2021

 

“B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology”

 

https://bdotmed.co.jp/en/news/20210625/


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
Subscribe Now